24 May 2013
Keywords: b-ms/merck, co, pargluva, sees, strong, ph, iii/ii
Article | 11 July 2005
Bristol-Myers Squibb and fellow US drugmaker Merck & Co have released strong results from a Phase III active-controlled study and a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 July 2005
23 May 2013
© 2013 thepharmaletter.com